157 related articles for article (PubMed ID: 27889902)
1. Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.
Chiba Y; Sato S; Itamochi H; Suga Y; Fukagawa T; Oumi N; Oishi T; Harada T; Sugai T; Sugiyama T
Hum Cell; 2017 Apr; 30(2):140-148. PubMed ID: 27889902
[TBL] [Abstract][Full Text] [Related]
2. [Carcinosarcomas of the uterus: molecular-genetic and morphological features].
Levitskaia NV; Pozharisskiĭ KM; Vostriukhina OA; Alekseeva LN; Nemtsova MV; Matrosova IV; Kharitonova TV; Poddubnaia IV
Arkh Patol; 2012; 74(1):7-11. PubMed ID: 22712296
[TBL] [Abstract][Full Text] [Related]
3. KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
Tang FH; Hsieh TH; Hsu CY; Lin HY; Long CY; Cheng KH; Tsai EM
Int J Cancer; 2017 Apr; 140(8):1860-1869. PubMed ID: 28032649
[TBL] [Abstract][Full Text] [Related]
4. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
5. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
[No Abstract] [Full Text] [Related]
6. Establishment and characterization of carcinosarcoma cell line of the human uterus.
Gorai I; Doi C; Minaguchi H
Cancer; 1993 Feb; 71(3):775-86. PubMed ID: 8431860
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract][Full Text] [Related]
8. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.
Itamochi H; Kato M; Nishimura M; Oumi N; Oishi T; Shimada M; Sato S; Naniwa J; Sato S; Nonaka M; Kudoh A; Terakawa N; Kigawa J; Harada T
Hum Cell; 2013 Sep; 26(3):121-7. PubMed ID: 23430509
[TBL] [Abstract][Full Text] [Related]
10. Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing.
Oumi N; Itamochi H; Komatsu H; Oishi T; Shimada M; Sato S; Chikumi J; Sato S; Nonaka M; Kudoh A; Harada T
Hum Cell; 2016 Jan; 29(1):46-51. PubMed ID: 26070481
[TBL] [Abstract][Full Text] [Related]
11. Integrated Molecular Characterization of Uterine Carcinosarcoma.
Cherniack AD; Shen H; Walter V; Stewart C; Murray BA; Bowlby R; Hu X; Ling S; Soslow RA; Broaddus RR; Zuna RE; Robertson G; Laird PW; Kucherlapati R; Mills GB; ; Weinstein JN; Zhang J; Akbani R; Levine DA
Cancer Cell; 2017 Mar; 31(3):411-423. PubMed ID: 28292439
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
[TBL] [Abstract][Full Text] [Related]
13. Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.
Hembree TN; Teer JK; Hakam A; Chiappori AA
Cancer Control; 2016 Jan; 23(1):61-6. PubMed ID: 27009459
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.
Cuppens T; Depreeuw J; Annibali D; Thomas D; Hermans E; Gommé E; Trinh XB; Debruyne D; Moerman P; Lambrechts D; Amant F
Gynecol Oncol; 2017 Sep; 146(3):538-545. PubMed ID: 28625393
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a newly established uterine carcinosarcoma cell line featuring the sarcomatous phenotype of the tumor in vitro.
Schulten HJ; Wolf-Salgó J; Gründker C; Gunawan B; Füzesi L
Int J Gynecol Cancer; 2008; 18(2):339-44. PubMed ID: 18334012
[TBL] [Abstract][Full Text] [Related]
17. Histogenesis of carcinosarcoma and establishment of leiomyosarcoma cell line (HTMMT) derived from human uterine carcinosarcoma.
Ishiwata I; Ishiwata C; Soma M; Iguchi M; Kiguchi K; Tamagawa T; Ishiwata I; Ishikawa H
Hum Cell; 2004 Sep; 17(3):131-7. PubMed ID: 15859158
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.
Sato S; Itamochi H; Oumi N; Chiba Y; Oishi T; Shimada M; Sato S; Chikumi J; Nonaka M; Kudoh A; Komatsu H; Harada T; Sugiyama T
Hum Cell; 2016 Oct; 29(4):181-7. PubMed ID: 26960408
[TBL] [Abstract][Full Text] [Related]
19. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: molecular evidence for monoclonal origin of the tumour.
Bai Q; Zhang X; Zhu X; Wang L; Huang D; Cai X; Zhou X; Wang J; Sheng W
Histopathology; 2016 Sep; 69(3):393-405. PubMed ID: 27307095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
